Cargando…

Quality and safety issues related to traditional animal medicine: role of taurine

BACKGROUND: Calculus Bovis (:C.Bovis) is one of the most precious and commonly-used medicinal materials in Japan and China. As the natural occurrence is very rare, a source of supply for C. Bovis is far behind the actual need and great efforts have been taken for some substitutes of natural C. Bovis...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Kyoko, Azuma, Yuko, Shimada, Kayoko, Saito, Tadashi, Kawase, Masaya, Schaffer, Stephen W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994370/
https://www.ncbi.nlm.nih.gov/pubmed/20804621
http://dx.doi.org/10.1186/1423-0127-17-S1-S44
_version_ 1782192923469676544
author Takahashi, Kyoko
Azuma, Yuko
Shimada, Kayoko
Saito, Tadashi
Kawase, Masaya
Schaffer, Stephen W
author_facet Takahashi, Kyoko
Azuma, Yuko
Shimada, Kayoko
Saito, Tadashi
Kawase, Masaya
Schaffer, Stephen W
author_sort Takahashi, Kyoko
collection PubMed
description BACKGROUND: Calculus Bovis (:C.Bovis) is one of the most precious and commonly-used medicinal materials in Japan and China. As the natural occurrence is very rare, a source of supply for C. Bovis is far behind the actual need and great efforts have been taken for some substitutes of natural C. Bovis. Unfortunately, very little information is available on the quality and/or clinical efficacy of medication based on C. Bovis. To ensure sustainable use of traditional therapeutic agents derived from C. Bovis, we felt that several issues needed to be addressed: 1) the source of the C. Bovis materials and quality control; 2) the role of taurine in the efficacy of C. Bovis. METHODS: Nine samples of natural C. Bovis and its substitutes were collected. ICP-MS was used for elemental analysis and the characterization was performed by principal component analysis (PCA) and soft independent modeling of class analogy (SIMCA) as multivariate approaches. The efficacy of C. Bovis was evaluated for morphology, viability and beating pattern on cultured cardiac myocytes and/or fibroblasts. RESULTS: PCA and multi-elemental focus was effective in discriminating C. Bovis samples derived from different habitats. A satisfactory classification using SIMCA was obtained among Australia C. Bovis, other habitats and the substitutes. Australian samples had better batch uniformity than other habitats and were composed of fewer elements. We have used Australian C. Bovis for assessment on its bioactive compounds. Rat cardiac cells incubated with C. Bovis extract (0.01-0.1mg/ml) maintained normal morphology, viability and beating pattern. Cardiac myocytes and fibroblasts treated for 48 h with CA (0.5mM) or DCA (0.1mM) caused cell injury, as reflected by changes in appearance and a reduction of viability detected by the MTS assay. In cardiomyocytes, 0.5 h exposure of CA (0.5mM) markedly decreased the velocity ratio of beating, whereas the simultaneous addition of 1 mM taurine largely prevented the decrease. CONCLUSIONS: The multi-elemental focus provided some references for the quality control and the efficacy of C. Bovis. Taurine partly attenuated the harmful actions of bile acids. It is plausible that the relationship between taurine and the bile acids contributes to therapeutic effect of C. Bovis.
format Text
id pubmed-2994370
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29943702010-12-01 Quality and safety issues related to traditional animal medicine: role of taurine Takahashi, Kyoko Azuma, Yuko Shimada, Kayoko Saito, Tadashi Kawase, Masaya Schaffer, Stephen W J Biomed Sci Review BACKGROUND: Calculus Bovis (:C.Bovis) is one of the most precious and commonly-used medicinal materials in Japan and China. As the natural occurrence is very rare, a source of supply for C. Bovis is far behind the actual need and great efforts have been taken for some substitutes of natural C. Bovis. Unfortunately, very little information is available on the quality and/or clinical efficacy of medication based on C. Bovis. To ensure sustainable use of traditional therapeutic agents derived from C. Bovis, we felt that several issues needed to be addressed: 1) the source of the C. Bovis materials and quality control; 2) the role of taurine in the efficacy of C. Bovis. METHODS: Nine samples of natural C. Bovis and its substitutes were collected. ICP-MS was used for elemental analysis and the characterization was performed by principal component analysis (PCA) and soft independent modeling of class analogy (SIMCA) as multivariate approaches. The efficacy of C. Bovis was evaluated for morphology, viability and beating pattern on cultured cardiac myocytes and/or fibroblasts. RESULTS: PCA and multi-elemental focus was effective in discriminating C. Bovis samples derived from different habitats. A satisfactory classification using SIMCA was obtained among Australia C. Bovis, other habitats and the substitutes. Australian samples had better batch uniformity than other habitats and were composed of fewer elements. We have used Australian C. Bovis for assessment on its bioactive compounds. Rat cardiac cells incubated with C. Bovis extract (0.01-0.1mg/ml) maintained normal morphology, viability and beating pattern. Cardiac myocytes and fibroblasts treated for 48 h with CA (0.5mM) or DCA (0.1mM) caused cell injury, as reflected by changes in appearance and a reduction of viability detected by the MTS assay. In cardiomyocytes, 0.5 h exposure of CA (0.5mM) markedly decreased the velocity ratio of beating, whereas the simultaneous addition of 1 mM taurine largely prevented the decrease. CONCLUSIONS: The multi-elemental focus provided some references for the quality control and the efficacy of C. Bovis. Taurine partly attenuated the harmful actions of bile acids. It is plausible that the relationship between taurine and the bile acids contributes to therapeutic effect of C. Bovis. BioMed Central 2010-08-24 /pmc/articles/PMC2994370/ /pubmed/20804621 http://dx.doi.org/10.1186/1423-0127-17-S1-S44 Text en Copyright ©2010 Takahashi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Takahashi, Kyoko
Azuma, Yuko
Shimada, Kayoko
Saito, Tadashi
Kawase, Masaya
Schaffer, Stephen W
Quality and safety issues related to traditional animal medicine: role of taurine
title Quality and safety issues related to traditional animal medicine: role of taurine
title_full Quality and safety issues related to traditional animal medicine: role of taurine
title_fullStr Quality and safety issues related to traditional animal medicine: role of taurine
title_full_unstemmed Quality and safety issues related to traditional animal medicine: role of taurine
title_short Quality and safety issues related to traditional animal medicine: role of taurine
title_sort quality and safety issues related to traditional animal medicine: role of taurine
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994370/
https://www.ncbi.nlm.nih.gov/pubmed/20804621
http://dx.doi.org/10.1186/1423-0127-17-S1-S44
work_keys_str_mv AT takahashikyoko qualityandsafetyissuesrelatedtotraditionalanimalmedicineroleoftaurine
AT azumayuko qualityandsafetyissuesrelatedtotraditionalanimalmedicineroleoftaurine
AT shimadakayoko qualityandsafetyissuesrelatedtotraditionalanimalmedicineroleoftaurine
AT saitotadashi qualityandsafetyissuesrelatedtotraditionalanimalmedicineroleoftaurine
AT kawasemasaya qualityandsafetyissuesrelatedtotraditionalanimalmedicineroleoftaurine
AT schafferstephenw qualityandsafetyissuesrelatedtotraditionalanimalmedicineroleoftaurine